14 May 2024
Innovations in TMVR and Intrepid trial updates
Sponsored by Medtronic
Anchorperson:
A. Duncan
Summary
Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of transitioning from a transapical to a transfemoral approach, with patients experiencing favorable outcomes. This shift offers a viable alternative for individuals ineligible for edge-to-edge procedures or those unlikely to benefit from them.
Learning Objectives
- To gain insights on the APOLLO TMVR trial
- To better understand the treatment goals of mitral regurgitation elimination
- To learn about early APOLLO EU trial experience
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide020.jpg)
/slide021.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)